7,425.25

+23.25

+0.31%

51,709.00

+324.00

+0.63%

27,072.50

-12.75

-0.05%

Russell 2000 Futures

2,780.10

+19.60

+0.71%

4.8590

+0.0220

+0.45%

25.64

-2.54

-9.01%

4,116.30

+41.40

+1.02%

74,048.14

-1,807.82

-2.38%

Crude Oil Dec 26

89.75

-1.08

-1.19%

US Private Equity

10,772.76

+11.83

+0.11%

NasdaqGM - Nasdaq Real Time Price USD

TELA Bio, Inc. (TELA)

0.8200 +0.0400 (+5.13%)

At close: November 6 at 4:00:00 PM EST

Loading Chart for TELA

Chart Range Bar

Interval:

In partnership with ChartIQ

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio to Announce Third Quarter 2026 Financial Results

TELA Bio to Announce Third Quarter 2026 Financial Results

TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement

TELA Bio Announces 510(k) Clearance for Liora™ Monofilament Scaffold for Soft Tissue Reinforcement

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

TELA Bio Announces COO / CFO Transition and Strategic Cost Reduction Initiative

TELA Bio (TELA) Q2 2026 Earnings Call Transcript

TELA Bio (TELA) Q2 2026 Earnings Call Transcript

TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ...

TELA Bio Inc (TELA) (Q2 2026) Earnings Call Highlights: Navigating PRS Headwinds and Strategic ...

TELA Bio Reports Second Quarter 2026 Financial Results

TELA Bio Reports Second Quarter 2026 Financial Results

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

TELA Bio to Participate in the Canaccord Genuity 46th Annual Growth Conference

TELA Bio to Announce Second Quarter 2026 Financial Results

TELA Bio to Announce Second Quarter 2026 Financial Results

Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25

Earnings Release: Here's Why Analysts Cut Their TELA Bio, Inc. (NASDAQ:TELA) Price Target To US$2.25

Mobilize your Website

View Site in Mobile | Classic

Share by: